Market Overview

UPDATE: UBS Raises PT to $11 on Cott on Improving Margins and Free Cash Flows

Related COT
Bank Of America Upgrades Dr Pepper Snapple; Analysts Still Prefer Other Soft Drinks
Top 4 NYSE Stocks In The Beverages-Soft Drinks Industry With The Highest EPS Growth Forecast For Next 5 Years

UBS reiterated its Buy rating on Cott (NYSE: COT) and increased its price target from $10 to $11.

UBS noted, "We do not believe that COT is trading in-line with its ability to consistently generate FCF. We are raising our EPSe to account for debt paydown (lower interest). Following the debt paydown, during which they can pay dividend and repurchase shares, we assume bigger buybacks. In the interim, Cott's margin profile should improve as efficiencies are realized and cost inflation moderates."

Cott closed at $8.10 on Friday.

Latest Ratings for COT

DateFirmActionFromTo
Nov 2014CitigroupMaintainsBuy
Oct 2014CitigroupMaintainsBuy
Oct 2014JefferiesMaintainsHold

View More Analyst Ratings for COT
View the Latest Analyst Ratings

Posted-In: UBSAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (COT)

Around the Web, We're Loving...

Get Benzinga's Newsletters